Ondine Biomedical Inc (LON:OBIMF) | WebDisclosure

Basculer en Français

10093	Companies
206623	Keywords
136808	Articles
109530	Press releases

Headlines Articles Press releases Ondine Biomedical Inc

Home
Companies
Ondine Biomedical Inc

PRESS RELEASE

published on 04/15/2024 at 08:00, 1 year 11 months ago

Ondine Biomedical Inc. Announces 32% Fewer SSIs After Steriwave Replaced Mupirocin
Study at Mazankowski Alberta Heart Institute shows 32% reduction in cardiac infections with Steriwave replacing antibiotic standard. Significant cost savings and high compliance. Expert commentary available

Steriwave Cost Savings Mazankowski Alberta Heart Institute Cardiac Infections Antimicrobial Treatment
BRIEF

published on 04/10/2024 at 08:05, 1 year 11 months ago

Ondine Biomedical Inc.'s Steriwave Cleared for Use in HCA Healthcare UK Facilities

Antimicrobial Resistance Steriwave Healthcare-associated Infections HCA Healthcare UK Antibiotic Reduction
BRIEF

published on 04/10/2024 at 08:05, 1 year 11 months ago

Steriwave d'Ondine Biomedical Inc. autorisé à être utilisé dans les établissements HCA Healthcare au Royaume-Uni

Steriwave Infections Nosocomiales Résistance Aux Antimicrobiens HCA Healthcare Royaume-Uni Réduction Des Antibiotiques
PRESS RELEASE

published on 04/10/2024 at 08:00, 1 year 11 months ago

Ondine Biomedical Inc. Announces Steriwave Authorized for use by HCA UK
HCA UK authorizes Steriwave antimicrobial by Ondine Biomedical to combat healthcare-associated infections without inducing antimicrobial resistance. Approval allows wider adoption in healthcare facilities

Antimicrobial Resistance Healthcare Facilities Steriwave Ondine Biomedical HCA UK
BRIEF

published on 04/04/2024 at 08:05, 1 year 11 months ago

Ondine Biomedical Inc. Expands into ICU Market with Steriwave®

Antimicrobial Resistance Steriwave Ondine Biomedical Healthcare-associated Infections Intensive Care Unit
BRIEF

published on 04/04/2024 at 08:05, 1 year 11 months ago

Ondine Biomedical Inc. se développe sur le marché des soins intensifs avec Steriwave®

Steriwave Ondine Biomedical Infections Nosocomiales Résistance Aux Antimicrobiens Unité De Soins Intensifs
PRESS RELEASE

published on 04/04/2024 at 08:00, 1 year 11 months ago

Ondine Biomedical Inc. Announces Entry into ICU Market Expands Revenue Potential
Ondine Biomedical plans entry into ICU market following interest from Canadian Hospitals. The move aims to reduce infections with Steriwave® treatment without triggering antimicrobial resistance. Cost savings for hospitals expected

Antimicrobial Resistance Ondine Biomedical ICU Market Steriwave® Hospital Infections
BRIEF

published on 03/25/2024 at 08:05, 2 years ago

Ondine Biomedical Inc. Achieves Commercial Adoption of Steriwave in NHS Hospitals

Antimicrobial Resistance Ondine Biomedical Inc. Steriwave Surgical Site Infections NHS
BRIEF

published on 03/25/2024 at 08:05, 2 years ago

Ondine Biomedical Inc. parvient à l'adoption commerciale de Steriwave dans les hôpitaux du NHS

Steriwave Infections Du Site Opératoire NHS Ondine Biomédicale Inc. Résistance Aux Antimicrobiens
PRESS RELEASE

published on 03/25/2024 at 08:00, 2 years ago

Ondine Biomedical Inc. Announces First commercial adoption of Steriwave by the NHS
NHS hospitals adopt groundbreaking light-activated antimicrobial, Steriwave, to combat AMR and reduce surgical infections. Ondine Biomedical partners with NHS for further adoption

Steriwave Ondine Biomedical NHS Hospitals Light-activated Antimicrobial Surgical Infections

Accesswire

Published on 03/26/2026 at 08:05, 1 hour 34 minutes ago

Vanta Announces U.S. Ticker Symbol Change to VNTXF
Published on 03/26/2026 at 04:55, 4 hours 44 minutes ago

Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives
Published on 03/26/2026 at 00:40, 8 hours 59 minutes ago

Challenger RC Resource Upgrade Drilling Complete
Published on 03/26/2026 at 00:30, 9 hours 9 minutes ago

Nano One Highlights Recent Objectives & Reports Fourth Quarter 2025 Results
Published on 03/25/2026 at 19:15, 14 hours 24 minutes ago

Gemina Laboratories Ltd. Announces Delisting from the CSE

View all ACCESSWIRE

EQS Group

Published on 03/26/2026 at 09:20, 18 minutes ago

yoummday Wins a Texas Instruments 2025 Supplier Excellence Award
Published on 03/26/2026 at 09:10, 28 minutes ago

Uppsala first in the world with IQ tourism
Published on 03/26/2026 at 09:05, 33 minutes ago

Rockwell Automation Showcases Autonomous Industrial Operations at Hannover Messe 2026
Published on 03/26/2026 at 09:00, 38 minutes ago

Original-Research: ZEAL Network SE (von NuWays AG): BUY
Published on 03/26/2026 at 09:00, 38 minutes ago

Original-Research: INDUS Holding AG (von NuWays AG): BUY

Les Echos

Published on 03/26/2026 at 08:57, 41 minutes ago

Communiqué Edenred
Published on 03/26/2026 at 08:57, 41 minutes ago

Edenred statement
Published on 03/26/2026 at 07:30, 2 hours 9 minutes ago

BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/26/2026 at 07:30, 2 hours 9 minutes ago

BIOPHYTIS ET LYNXKITE INVITÉS À LA CONFÉRENCE NVIDIA : L’IA AU SERVICE DE LA LONGÉVITÉ
Published on 03/25/2026 at 18:53, 14 hours 45 minutes ago

CIS - Transfert Contrat de Liquidité Portzamparc - 25.03.2026

View all LES ECHOS COMFI WIRE